Risk factors for chronic renal dysfunction in cardiac allograft recipients

被引:33
|
作者
Esposito, C
Semeraro, L
Bellotti, N
Fasoli, G
Fornoni, A
Rampino, T
Klersy, C
Campana, C
Gavazzi, A
Viganò, M
Dal Canton, A
机构
[1] Univ Pavia, IRCCS, Policlin San Matteo, Dept Internal Med & Nephrol, I-27100 Pavia, Italy
[2] Univ Pavia, IRCCS, Policlin San Matteo, Div Cardiol, I-27100 Pavia, Italy
[3] Univ Pavia, IRCCS, Policlin San Matteo, Div Cardiac Surg, I-27100 Pavia, Italy
[4] Univ Pavia, IRCCS, Policlin San Matteo, Sci Adm, I-27100 Pavia, Italy
来源
NEPHRON | 2000年 / 84卷 / 01期
关键词
cardiac allograft recipients; renal function; heart transplantation; ciclosporin;
D O I
10.1159/000045534
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Renal dysfunction is one of the most common and threatening complications in heart transplant recipients. Even if ciclosporin seems to play a central role in inducing renal damage, other factors may concur or predispose to renal injury. In order to identify factors responsible for renal dysfunction, we retrospectively studied a cohort of 114 cardiac transplant recipients during a follow-up period of at least 3 years. The patients had a normal renal function before and 0.5 months after heart transplantation. Doubling of baseline serum creatinine or attainment of serum creatinine steadily above 176.8 mu mol/l (2.0 mg/dl) was used as criterion to define the end-point renal dysfunction. A series of clinical and laboratory variables were obtained from the patients' charts at different time intervals, and their prognostic value for the occurrence of renal dysfunction was calculated by Cox proportional hazards models. 23 out of 114 patients reached the end point after a median time period of 21 months. High serum triglyceride, alanine aminotransferase, alkaline phosphatase, ciclosporin, urea, glucose, and hemoglobin levels were shown to be associated with the development of renal dysfunction. Four variables, i.e., triglyceride, ciclosporin, urea, and alkaline phosphatase, had an independent prognostic value. Our results confirm a role for ciclosporin in inducing renal dysfunction and identify hyperlipidemia and an increased plasma urea level as risk factors for renal dysfunction in heart transplant recipients. Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:21 / 28
页数:8
相关论文
共 50 条
  • [21] Primary Graft Dysfunction in Heart Transplant Recipients-Risk Factors and Longitudinal Outcomes
    Smith, Nicholas F.
    Omran, Sina Salehi
    Genuardi, Michael, V
    Horn, Edward T.
    Kilic, Arman
    Sciortino, Christopher M.
    Keebler, Mary E.
    Kormos, Robert L.
    Hickey, Gavin W.
    ASAIO JOURNAL, 2022, 68 (03) : 394 - 401
  • [22] VEGF-C, VEGF-A and related angiogenesis factors as biomarkers of allograft vasculopathy in cardiac transplant recipients
    Daly, Kevin P.
    Seifert, Michael E.
    Chandraker, Anil
    Zurakowski, David
    Nohria, Anju
    Givertz, Michael M.
    Karumanchi, S. Ananth
    Briscoe, David M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (01): : 120 - 128
  • [23] Angiogenic growth factors in cardiac allograft rejection
    Nykanen, Antti L.
    Tikkanen, Jussi M.
    Krebs, Rainer
    Keranen, Mikko A. I.
    Sihvola, Roope K.
    Sandelin, Henrik
    Tuuminen, Raimo
    Raisky, Olivier
    Koskinen, Petri K.
    Lemstrom, Karl B.
    TRANSPLANTATION, 2006, 82 (01) : S22 - S24
  • [24] Incidence of malignancies in cardiac allograft recipients - a single-center experience
    Sobieszczanska-Malek, Malgorzata
    Komuda, Krzysztof
    Piotrowska, Malgorzata
    Korewicki, Jerzy
    Malek, Grzegorz
    Leszek, Przemyslaw
    Zielinski, Tomasz
    ANNALS OF TRANSPLANTATION, 2013, 18 : 88 - 94
  • [25] Blood glutathione as a marker of cardiac allograft vasculopathy in heart transplant recipients
    De Chiara, B
    Bigi, R
    Campolo, J
    Parolini, M
    Turazza, F
    Masciocco, G
    Frigerio, M
    Fiorentini, C
    Parodi, O
    CLINICAL TRANSPLANTATION, 2005, 19 (03) : 367 - 371
  • [26] Pediatric Heart Transplant Recipients and Cardiac Allograft Vasculopathy The Importance of Hemodynamics
    Eisen, Howard J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (05) : 558 - 560
  • [27] Recipient hypertonic saline infusion prevents cardiac allograft dysfunction
    Ribeiro, Roberto V. P.
    Badiwala, Mitesh V.
    Ramzy, Danny
    Tumiati, Laura C.
    Rao, Vivek
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2019, 157 (02): : 615 - +
  • [28] Endothelial Dysfunction in Cardiac Allograft Vasculopathy: Potential Pharmacological Interventions
    Osto, Elena
    Tona, Francesco
    De Bon, Emiliano
    Iliceto, Sabino
    Cella, Guiseppe
    CURRENT VASCULAR PHARMACOLOGY, 2010, 8 (02) : 169 - 188
  • [29] Usefulness of extracorporeal membrane oxygenation for early cardiac allograft dysfunction
    Listijono, Dave R.
    Watson, Alasdair
    Pye, Roger
    Keogh, Anne M.
    Kotlyar, Eugene
    Spratt, Phillip
    Granger, Emily
    Dhital, Kumud
    Jansz, Paul
    Macdonald, Peter S.
    Hayward, Christopher S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (07): : 783 - 789
  • [30] Primary Cardiac Allograft Dysfunction-Validation of a Clinical Definition
    Dronavalli, Vamsidhar B.
    Rogers, Chris A.
    Banner, Nicholas R.
    TRANSPLANTATION, 2015, 99 (09) : 1919 - 1925